Gemphire Therapeutics Inc. (GEMP) has 15 open-market insider trades by 11 insiders since 2016. The most active filer is Steven R. Gullans Ph.D., CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven R. Gullans Ph.D. | CEOPres | — | 3 | $6.5M | 2019-07-24 |
| P. Kent Hawryluk | Dir | — | 2 | $724K | 2017-03-10 |
| Mina Sooch | CEOPres | — | 1 | $525K | 2016-08-10 |
| Charles Bisgaier Ph.D. | Chairman10% Owner | — | 1 | $518K | 2019-07-24 |
| Andy Sassine | Dir | — | 1 | $400K | 2019-07-24 |
| Pedro Lichtinger | Dir | — | 2 | $300K | 2019-07-24 |
| Seth Reno | CCO | — | 2 | $140K | 2019-07-24 |
| David Lowenschuss | CLOSecretary | — | 1 | $111K | 2016-08-10 |
| Jeffrey S. Mathiesen | CFO | — | 1 | $40K | 2017-08-14 |
| Jeffrey S. Mathiesen | CFO | — | 1 | $40K | 2017-08-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Seth Reno | CCO | Buy | $100K | 2018-02-08 |
| Steven R. Gullans Ph.D. | CEO & President | Buy | $500K | 2018-02-08 |
| Andy Sassine | Director | Buy | $400K | 2017-03-10 |
| P. Kent Hawryluk | Director | Buy | $474K | 2017-03-10 |
| Steven R. Gullans Ph.D. | Director | Buy | $1000K | 2017-03-10 |
| Pedro Lichtinger | Director | Buy | $200K | 2017-03-10 |
Companies that share insiders with GEMP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey S. Mathiesen | CFO | Buy | $40K | 2016-08-10 |
| Steven R. Gullans Ph.D. | Director | Buy | $5.0M | 2016-08-10 |
| David Lowenschuss | CLO & Secretary | Buy | $111K | 2016-08-10 |
| Charles Bisgaier Ph.D. | Chairman & 10% Owner | Buy | $518K | 2016-08-10 |
| Pedro Lichtinger | Director | Buy | $100K | 2016-08-10 |
| P. Kent Hawryluk | Director | Buy | $250K | 2016-08-10 |
| Mina Sooch | CEO & President | Buy | $525K | 2016-08-10 |
| Kenneth W. Kousky | Director | Buy | $10K | 2016-08-10 |